Triumvira Therapeutics is a clinical stage immunotherapy company focused on developing novel T-cell therapies that utilize their proprietary T-cell Antigen Coupler (TAC) technology to improve the efficacy and safety of cancer treatments
Triumvira Therapeutics is a clinical stage immunotherapy company focused on developing novel T-cell therapies that utilize their proprietary T-cell Antigen Coupler (TAC) technology to improve the efficacy and safety of cancer treatments.